Free Trial

FY2025 Earnings Forecast for SunOpta Issued By William Blair

SunOpta logo with Consumer Staples background

SunOpta Inc. (NASDAQ:STKL - Free Report) TSE: SOY - Equities research analysts at William Blair upped their FY2025 earnings estimates for shares of SunOpta in a research note issued on Tuesday, November 5th. William Blair analyst J. Andersen now expects that the company will earn $0.22 per share for the year, up from their prior estimate of $0.21. The consensus estimate for SunOpta's current full-year earnings is $0.14 per share.

STKL has been the subject of several other reports. Stephens raised their price objective on shares of SunOpta from $9.00 to $10.00 and gave the stock an "overweight" rating in a report on Wednesday. DA Davidson reiterated a "buy" rating and issued a $9.00 target price on shares of SunOpta in a research note on Thursday, October 10th. Finally, StockNews.com lowered SunOpta from a "hold" rating to a "sell" rating in a report on Friday, November 1st. One research analyst has rated the stock with a sell rating and four have given a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $9.50.

Get Our Latest Stock Analysis on SunOpta

SunOpta Trading Up 2.6 %

Shares of NASDAQ:STKL traded up $0.19 during trading on Thursday, reaching $7.45. 892,922 shares of the stock were exchanged, compared to its average volume of 811,939. The firm has a market cap of $889.90 million, a price-to-earnings ratio of -5.36 and a beta of 1.83. The company has a debt-to-equity ratio of 1.67, a quick ratio of 0.61 and a current ratio of 1.27. SunOpta has a 12-month low of $3.81 and a 12-month high of $7.59. The firm's 50-day moving average price is $6.30 and its 200 day moving average price is $5.89.

SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last issued its quarterly earnings results on Tuesday, November 5th. The company reported $0.02 earnings per share for the quarter, meeting the consensus estimate of $0.02. SunOpta had a positive return on equity of 6.51% and a negative net margin of 23.23%. The company had revenue of $176.22 million during the quarter, compared to the consensus estimate of $172.30 million.

Institutional Trading of SunOpta

A number of institutional investors have recently bought and sold shares of STKL. Royce & Associates LP boosted its position in shares of SunOpta by 9.3% during the third quarter. Royce & Associates LP now owns 1,538,496 shares of the company's stock worth $9,816,000 after purchasing an additional 130,470 shares in the last quarter. GSA Capital Partners LLP raised its stake in SunOpta by 16.9% during the 3rd quarter. GSA Capital Partners LLP now owns 212,462 shares of the company's stock worth $1,356,000 after buying an additional 30,646 shares during the period. Hollencrest Capital Management lifted its holdings in SunOpta by 1,600.0% during the third quarter. Hollencrest Capital Management now owns 17,000 shares of the company's stock worth $108,000 after acquiring an additional 16,000 shares in the last quarter. Harbor Capital Advisors Inc. grew its stake in SunOpta by 127.6% in the third quarter. Harbor Capital Advisors Inc. now owns 1,063,918 shares of the company's stock valued at $6,788,000 after acquiring an additional 596,403 shares during the period. Finally, US Bancorp DE increased its holdings in shares of SunOpta by 139.3% in the third quarter. US Bancorp DE now owns 8,197 shares of the company's stock worth $52,000 after acquiring an additional 4,772 shares in the last quarter. Institutional investors and hedge funds own 85.39% of the company's stock.

About SunOpta

(Get Free Report)

SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.

Featured Stories

Should you invest $1,000 in SunOpta right now?

Before you consider SunOpta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.

While SunOpta currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines